Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its latest quarterly report later this week. Experts are anticipating strong growth driven by the strong demand of Lilly's blockbuster drugs, particularly recent launches. However, there are also